Piermont Capital Management’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-34,430
Closed -$1M 124
2018
Q2
$1M Buy
34,430
+12,700
+58% +$386K 0.31% 114
2018
Q1
$650K Sell
21,730
-2,150
-9% -$69.8K 0.22% 134
2017
Q4
$820K Sell
23,880
-1,120
-4% -$36.7K 0.27% 118
2017
Q3
$744K Sell
25,000
-20,870
-45% -$601K 0.25% 121
2017
Q2
$1.32M Sell
45,870
-8,574
-16% -$221K 0.38% 109
2017
Q1
$1.27M Sell
54,444
-220
-0.4% -$5.17K 0.3% 134
2016
Q4
$1.16M Sell
54,664
-1,000
-2% -$21.9K 0.26% 149
2016
Q3
$1.26M Buy
55,664
+4,890
+10% +$112K 0.3% 131
2016
Q2
$1.16M Buy
50,774
+24,789
+95% +$662K 0.3% 127
2016
Q1
$728K Buy
25,985
+995
+4% +$24.8K 0.23% 111
2015
Q4
$607K Sell
24,990
-1,700
-6% -$35.3K 0.19% 122
2015
Q3
$439K Hold
26,690
0.14% 159
2015
Q2
$545K Buy
+26,690
New +$539K 0.16% 149

Other funds holding BRKR

Piermont Capital Management's BRKR Position: Q3 2018 in Review

Piermont Capital Management sold out of Bruker (BRKR) in Q3 2018, closing a stake of 34,430 shares — an estimated $1M sold.

Piermont Capital Management first reported a position in BRKR in Q2 2015 and held it in 13 quarters. The position peaked at $1.32M in Q2 2017. 221 funds tracked by Wall St. Rank hold BRKR as of Q3 2018.

  • Piermont Capital Management reported no remaining Bruker position as of Q3 2018 after selling out during the quarter.
  • Piermont Capital Management sold 34,430 Bruker shares in Q3 2018, an estimated $1M.
  • Piermont Capital Management first reported a position in Bruker in Q2 2015 and held it in 13 quarters.
  • Piermont Capital Management's Bruker position peaked at $1.32M in Q2 2017.
  • 221 funds tracked by Wall St. Rank held Bruker as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.